Mehdi H. Hamadani, MD
Professor of Medicine; Associate Director of Clinical Research; Cancer Center Scholar Endowed Chair, Section Chief of Hematologic Malignancies
Locations
- Froedtert Hospital
- Clinical Cancer Center - Froedtert Hospital
Specialties
- Hematology
- Medical Oncology
Languages
- English, Urdu, Hindi, Punjabi
Clinical Cancer Center - Froedtert Hospital
Education
- MD - Doctor of Medicine
Biography
Dr. Hamadani is a professor of medicine and chief of hematologic malignancies at the Medical College of Wisconsin (MCW) in Milwaukee, WI. He serves as the Associate Director of Clinical Research at the MCW Clinical Cancer Center and holds the Cancer Center Scholar Endowed Chair. Dr. Hamadani graduated with honors from King Edward Medical College (Pakistan), in 2001. He completed internal medicine residency from the University of Oklahoma followed by a fellowship in Hematology/Oncology at The Ohio State University. He is considered an international key opinion leader in the fields of hematopoietic cell transplantation, cellular therapy and lymphoid malignancies. He has authored over 450 peer-reviewed publications. As the Principal Protocol Officer for BMT CTN and Co-PI of MCW LAPS Grant he has extensive experience in clinical trial design and has been involved in the development and execution of several practice changing transplant clinical trials. He chairs the ASTCT Committee on Practice Guidelines and served as the Secretary of American Society for Transplant and Cellular Therapies (2024-26). His key areas of search include graft-versus-host disease (GvHD), developmental therapeutics for lymphoid malignancies and hematopoietic cell transplantation. His clinical expertise includes lymphomas, transplant, and CAR-T cell therapies. He considers mentoring junior faculty and trainees as his top-most priority.
Research Interests
Publications
-
(Runaas L, Fank S, Palen K, Szabo A, Rein L, Ying G, Salzman N, Samanas L, Abedin SM, Chhabra S, Hamadani M, Longo W, Shah NN, Haber J, Gradissimo A, Waters NR, Peled JU, Johnson B, Kearl T, Drobyski WR.) Blood Adv. 2026 Feb 03 PMID: 41632629 02/03/2026
-
Conditioning, MRD, and NPM1 comutation in the MORPHO trial.
(Levis MJ, Hamadani M, Chen YB.) Blood Adv. 2026 Jan 27;10(2):514-515 PMID: 41160800 PMCID: PMC12869865 10/29/2025
-
(Ghobadi A, Anagnostou T, Azzi J, Hamadani M, Logan B, Ahmed S, Bharadwaj S, Baird JH, Jacobson C, Locke FL, Ulrickson M, Reagan PM, Hemmer MT, Hu ZH, Luo ZC, Wang HL, Jung AS, Nahas M, Best T, Beygi S, Pasquini MC.) Transplant Cell Ther. 2026 Jan 10 PMID: 41525947 01/13/2026
-
(Aughey E, Shah NN, Hillard CJ, Rentscher KE, Hamadani M, Longo W, Devata S, Knight JM, Cusatis R.) Transplant Cell Ther. 2026 Jan 02 PMID: 41485560 SCOPUS ID: 2-s2.0-105029718493 01/05/2026
-
(Shahzad M, Amin MK, Irfan S, Ahsan R, Qasim H, Javed MJ, McGuirk M, Chaudhary SG, Anwar I, Yacoub A, Singh AK, Hamadani M, Mcguirk JP, Mushtaq MU.) Clin Lymphoma Myeloma Leuk. 2026 Jan;26(1):e32-e40 PMID: 40930937 PMCID: PMC12924662 09/11/2025
-
(Shahzad M, Amin MK, Irfan S, Vyas A, Ahsan R, Chaudhary SG, Anwar I, McGuirk M, Iftikhar R, Abdelhakim H, Singh AK, Hamadani M, Mcguirk JP, Mushtaq MU.) Clin Lymphoma Myeloma Leuk. 2026 Jan;26(1):e23-e31 PMID: 40930936 09/11/2025
-
(Ahmed S, Kumar A, Carpenter P, Herrera A, Kelly K, Pinnix C, Rutherford S, Grover N, Evens A, Lynch R, Kenkre V, Merryman R, Sauter C, Nishihori T, Moskowitz A, Awan F, Svoboda J, Winter J, Allen P, Ermoian R, Ansell S, Aljuhaishi T, Nieto Y, Hamadani M, Perales MA.) Transplant Cell Ther. 2025 Dec 30 PMID: 41478324 01/02/2026
-
(Ustun C, Zhang MJ, Peterson A, Baek A, Agha M, Alkhateeb H, Chhabra S, Coltoff A, de Lima M, Gandhi A, Ho V, Kassim A, Lin A, Gowda L, Borthakur G, DeAngelo DJ, McGuirk J, Mensah F, Nadiminti KV, Nishihori T, Pantin J, Trunk A, Uberti J, Marcucci G, Gotlib J, Akin C, Hamadani M, Pullarkat V, Valent P, Grunwald M, Juckett M, Oran B, Saber W, Burns LJ.) Br J Haematol. 2025 Dec;207(6):2486-2495 PMID: 40983528 PMCID: PMC12519450 SCOPUS ID: 2-s2.0-105016816308 09/23/2025
-
CD19 directed CAR T therapy for intravascular large B-cell lymphoma.
(Patel J, Gopal A, Cherniawsky H, Ram R, Kamble R, Hamadani M.) Haematologica. 2025 Nov 06 PMID: 41195517 11/06/2025
-
(Salles G, Fox CP, Hamadani M, Wang A, Sail K, Alshreef A, Moran M, Mutebi A, Blaedel J, Chirikov V, Thieblemont C.) Clin Lymphoma Myeloma Leuk. 2025 Nov;25(11):e986-e994.e4 PMID: 40903324 PMCID: PMC12425561 09/04/2025
-
(Spellman SR, Xu K, Oloyede T, Ahn KW, Akhtar OS, Bolon YT, Broglie L, Bloomquist J, Bupp C, Chen M, Devine SM, Jurdi NE, Hamadani M, Hengen M, Huppler AH, Jaglowski S, Kuxhausen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Pérez WS, Phelan R, Rizzo D, Saber W, Stefanski HE, Steinert P, Tuschl E, Visotcky A, Vogel R, Auletta JJ, Shaw BE, Allbee-Johnson M.) Transplant Cell Ther. 2025 Oct 07 PMID: 41027557 PMCID: PMC12606686 SCOPUS ID: 2-s2.0-105018107118 10/01/2025
-
(Hamby M, Egleston B, Frosch Z, Steiner R, Noy A, Carvajal V, Chong E, Tolu S, Jean-Louis G, Amengual J, Patel R, Ahmed S, Sharp J, Voorhees T, Baiocchi R, Ramirez-Gamero A, Castillo J, Hamburger E, Dittus C, Nizamuddin I, Mehta-Shah N, Dar NNT, Sandoval-Sus J, Rojek A, Riedell P, Khan N, Danilov A, Solipuram V, Rubinstein P, Ariotti A, Suneja G, Vartanov A, Milrod C, Olszewski A, Smilnak G, Ayers E, Desai S, Rhodes J, Magarelli G, Feldman T, Pellon M, Aboulafia D, Bae W, Galvez C, Bhatlapenumarthi V, Hamadani M, Barta S.) Res Sq. 2025 Sep 30 PMID: 41255989 PMCID: PMC12622178 11/19/2025